DRUG-DRUG INTERACTIONS BETWEEN PRIMAQUINE AND SSRI/SNRI ANTIDEPRESSANTS: IMPLICATIONS FOR PRIMAQUINE CO-ADMINISTRATION WITH CYP 2D6 INHIBITORS

被引：0
|
作者：
Jin, Xiannu [1 ]
Potter, Brittney [1 ]
Vuong, Chau [1 ]
Luong, Thu-lan [1 ]
Xie, Lisa [1 ]
Zhang, Jing [1 ]
Zhang, Ping [1 ]
Nelson, Jennifer [1 ]
Lee, Patricia [1 ]
Sousa, Jason [1 ]
Li, Qigui [1 ]
Read, Lisa [1 ]
Pybus, Brandon [1 ]
Kreishman-Deitrick, Mara [1 ]
Smith, Philip [1 ]
Paris, Robert [1 ]
Reichard, Gregory [1 ]
Marcsisin, Sean [1 ]
机构：
[1] Walter Reed Army Inst Res, Silver Spring, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2015年 / 93卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
255
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants
    Jin, Xiannu
    Potter, Brittney
    Luong, Thu-lan
    Nelson, Jennifer
    Chau Vuong
    Potter, Corttney
    Xie, Lisa
    Zhang, Jing
    Zhang, Ping
    Sousa, Jason
    Li, Qigui
    Pybus, Brandon S.
    Kreishman-Deitrick, Mara
    Hickman, Mark
    Smith, Philip L.
    Paris, Robert
    Reichard, Gregory
    Marcsisin, Sean R.
    MALARIA JOURNAL, 2016, 15
  • [2] Pre-clinical evaluation of CYP 2D6 dependent drug–drug interactions between primaquine and SSRI/SNRI antidepressants
    Xiannu Jin
    Brittney Potter
    Thu-lan Luong
    Jennifer Nelson
    Chau Vuong
    Corttney Potter
    Lisa Xie
    Jing Zhang
    Ping Zhang
    Jason Sousa
    Qigui Li
    Brandon S. Pybus
    Mara Kreishman-Deitrick
    Mark Hickman
    Philip L. Smith
    Robert Paris
    Gregory Reichard
    Sean R. Marcsisin
    Malaria Journal, 15
  • [3] The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness
    Monte, Andrew A.
    Heard, Kennon J.
    Campbell, Jenny
    Hamamura, D.
    Weinshilboum, Richard M.
    Vasiliou, Vasilis
    ACADEMIC EMERGENCY MEDICINE, 2014, 21 (08) : 879 - 885
  • [4] The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Efficacy
    Monte, A. A.
    Heard, K. J.
    Campbell, J.
    Weinshilboum, R. M.
    Vasiliou, V.
    ANNALS OF EMERGENCY MEDICINE, 2013, 62 (04) : S158 - S159
  • [5] The potential for clinically significant drug-drug interactions in patients receiving CYP 2D6 model substrate/drugs and fluoxetineiparoxetine or sertraline
    Preskorn, SH
    Shah, R
    Silkey, B
    Neff, M
    Golbeck, A
    Choi, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S285 - S285
  • [6] Database analyses for drug-drug interactions involving CYP2D6 inhibition
    Ito, K
    Hallifax, D
    Obach, RS
    Houston, JB
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49
  • [7] In Silico Model for Predicting CYP2D6-Mediated Drug-Drug Interactions
    Lozano, Roberto
    Frutos, Alberto
    Martinez, Alejandro
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (02) : 124 - 127
  • [8] Contribution of drug ionization to prediction of hepatic clearance and drug-drug interactions for CYP2D6
    Rougee, Luc R. A.
    Mohutsky, Michael A.
    Bedwell, David B.
    Ruterbories, Kenneth J.
    Hall, Stephen D.
    DRUG METABOLISM REVIEWS, 2016, 48 : 24 - 25
  • [9] The potential for clinically significant drug-drug interactions in patients receiving CYP 2D6 model substrate/drugs and fluoxetine/paroxetine or sertraline.
    Preskorn, SH
    Shah, R
    Silkey, B
    Neff, M
    Golbeck, A
    Choi, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P71 - P71
  • [10] Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug-Drug Interaction with Antidepressants
    MacLeod, A. Kenneth
    McLaughlin, Lesley A.
    Henderson, Colin J.
    Wolf, C. Roland
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (01) : 17 - 22
12345